Rudzki, Jakob D.
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 1 February 2019
Accepted: 20 June 2019
First Online: 12 July 2019
Conflict of interest
: J.D Rudzki declares that he has received honoraria and speaker’s fee from Gilead-Kite, Novartis, Celgene, BMS, Roche, MSD, AstraZeneca, Amgen and served as an advisor for Gilead-Kite, Novartis, Celgene, BMS, Roche, MSD, AstraZeneca, Amgen.